蛋白酶激活受体家族与创面愈合 代初发现的一种跨膜7次的G蛋白偶联受体,主要通过血小板膜上的该类受体发挥其激活血小板和促凝血的作用,因此又称为凝血酶受体(thrombin receptor, TR)[1].国内黄跃生等[2]提出凝血酶肽类对创面愈合及表皮细胞生长具有促进作用.国外研究证明,PAR在
基于4个网页-相关网页
Thrombin Receptor Agonist 凝血酶受体兴奋剂
thrombin receptor activating peptide 凝血酶受体活化肽
antisense thrombin receptor 反义凝血酶受体
thrombin receptor antagonist 凝血酶受体抑制剂
Antisense thrombin receptor gene 反义凝血酶受体基因
thrombin receptor agonist peptide 凝血酶受体激动剂肽
human thrombin receptor precursor 凝血酶受体前体
Antisense thrombin receptor oligo-deoxy-nucleotides 反义凝血酶受体寡核苷酸
receptor thrombin 凝血酶受体
Three anti-platelet thrombin receptor monoclonal antibodies were reported in France.
抗血小板膜糖蛋白凝血酶受体的单抗法国、日本和美国先后各报道了一株。
参考来源 - 抗血小板膜糖蛋白凝血酶受体单克隆抗体的制备、鉴定及功能研究·2,447,543篇论文数据，部分数据来源于NoteExpress
以上来源于: WordNet
Objective To investigate the effects of the thrombin receptor activating peptide (TP508) on healing of ischemic wound and flap survival in rats.
目的探讨凝血酶受体激活肽（TP5 0 8）对促进缺血创面愈合与皮瓣存活的作用。
Also disclosed are pharmaceutical compositions and combinations containing said compounds and their USES as thrombin receptor antagonists and binders to cannabinoid receptors.
本发明还公开了含有所述化合物的药物组合物和药物联用以及它们用作凝血酶受体拮抗剂和类大麻醇受体结合剂的用途。
Objective to investigate the actions of protease-activated receptor 1 (PAR1) agonists and thrombin on the secretion of interleukin-8 (IL-8) from human lung epithelial cells.
目的探讨蛋白酶激活受体1 (PAR1)激动肽和凝血酶对人肺上皮细胞白细胞介素- 8 (IL - 8)分泌的影响。
应用推荐